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The effect of iron on H,O, production by mouse peritoneal macrophages exposed to opsonised zymosan 
has been investigated. Macrophages elicited with thioglycollate broth produced less H,O, than macrophages 
activated by Corynebacterium parvum, and levels were not affected by prior incubation of the cells with 0.1 
mM iron nitrilotriacetate. However, preincubation with the iron chelator desferrioxamine (1 mM) reduced 
H,O, production by both types of macrophages. Incubation of macrophages with agar, a component of 
thioglycollate broth, also reduced H,O, production, particularly by C. parvum-activated macrophages. The 
results indicate that although iron appears to be necessary for H,O, production by macrophages, the low 
level of production by thioglycollate-elicited macrophages i not due to an inadequate level of metabolically 
utilisable iron, but may be a result of prior ingestion of agar present in the broth. 
Macrophage Macrophage activation 
1. INTRODUCTION 
It is well known that mouse peritoneal 
macrophages elicited with thioglycollate broth pro- 
duce only low levels of reactive oxygen compounds 
when triggered with agents such as phorbol esters 
or opsonised zymosan. In contrast, activated 
macrophages obtained following intraperitoneal 
injection of mycobacteria or Corynebacterium 
parvum (also known as Propionibacterium acnes) 
produce much greater quantities of these com- 
pounds and it is thought that this may account for 
their tumoricidal activity [l]. The reason for this 
difference is, however, not well understood. 
As part of a study of the mechanisms involved 
in the anaemia of chronic disease, we have recently 
investigated the way in which iron is handled by 
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resident, thioglycollate-stimulated and C. parvum- 
activated mouse peritoneal macrophages. These in- 
vestigations suggested that thioglycollate-elicited 
macrophages divert intracellular iron to a func- 
tionally inert pool, their metabolically-active iron 
pool being consequently reduced [2]. Since iron 
may be involved in oxygen metabolism, e.g. as a 
component of cytochromes it seemed possible that 
insufficient metabolically-active intracellular iron 
might account for the reduced production of reac- 
tive oxygen compounds by thioglycollate-elicited 
macrophages. However, it has also been suggested 
that agar present in thioglycollate broth may be 
taken up by macrophages and inhibit Hz02 pro- 
duction [3,4], though this has not been shown ex- 
perimentally. This work has therefore sought to 
determine whether either intracellular iron or agar 
can affect production of Hz02 by mouse peritoneal 
macrophages, and whether any effect of agar is 
mediated by a disturbance of intracellular iron 
metabolism. 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/86/$3.50 0 1986 Federation of European Biochemical Societies 283 
Volume 200, number 2 FEBS LETTERS May 1986 
2. MATERIALS AND METHODS 
2.1. Macrophages 
Thioglycollate-elicited mouse peritoneal macro- 
phages were obtained from adult BALB/C mice 4 
days after stimulation as described by Esparza and 
Brock [5]. C. pam,um-activated macrophages were 
harvested 4 days after intraperitoneal injection of 
2 mg of freeze-dried C. parvum strain 4982, kindly 
provided by Professor P.C. Wilkinson. Monolayer 
cultures (1 ml) were prepared in multiwell plates 
from 5 x lo6 cells in 1 ml of RPM1 1640 medium 
containing 10% fetal calf serum (both from Flow 
Laboratories, Irvine, Scotland). Non-adherent 
cells were removed after 2 h incubation at 37°C in 
10% CO#O% air in a humidified incubator. 
2.2. HZOZ production 
The procedure of Ruth et al. [6] was used, which 
utilises the oxidation of homovanillic acid to a 
fluorescent dimer. This method was found in 
preliminary experiments to have excellent sensitivi- 
ty and reproducibility when used with adherent 
macrophage cultures. Cells were triggered as 
described by Ruth et al. [6] by incubating for 1 h 
in a total volume of 2 ml with zymosan (2 mg per 
culture: Sigma, Poole) which had been opsonised 
by incubating for 15 min with 50% (v/v) fresh 
mouse serum. The supernatants were centrifuged 
at 700 x g for 10 min to remove the zymosan and 
any non-adherent cells before reading in a Perkin- 
Elmer 1000 Fluorimeter. The adherent cells were 
dissolved in 2% (w/v) SDS and total cell protein 
estimated by the Lowry method. Results were ex- 
pressed as nmol Hz02 released per pg of cell 
protein. 
2.3. Iron release 
The ability of macrophages to release iron was 
determined using a method described previously 
[5] in which cells are pulsed with ‘%e transferrin- 
antitransferrin immune complexes, and subse- 
quent release of soluble %e to the culture super- 
natant is measured. Each well received 10 fig of 
labelled transferrin, as immune complexes. 
2.4. Addition or depletion of iron 
Following removal of non-adherent cells, the 
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macrophages were either loaded with iron by in- 
cluding 0.1 mM Fe as the nitrilotriacetate complex 
(FeNTA) or depleted of iron by including 1 mM 
desferrioxamine (DFO: Desferal, Ciba-Geigy, 
Horsham, Sussex) in the culture medium. Cultures 
were incubated for 2 h or overnight, washed twice 
with Hanks buffered salts solution and rein- 
cubated for a further 1 h in fresh medium to allow 
any internalised DFO or nitrilotriacetate to be 
released before washing, triggering the cells with 
opsonised zymosan and assaying for Hz02 produc- 
tion as described above. To test the effect of DFO 
on iron release, cells were pulsed with “Fe- 
transferrin-antitransferrin immune complexes as 
described above prior to overnight incubation with 
DFO, after which “Fe in the culture supernatant 
was determined. 
2.5. Addition of agar 
A solution (5 mg/ml) of agar (Oxoid) was 
prepared in boiling phosphate-buffered saline, 
cooled to 45°C and diluted 1: 10 in culture medium 
pre-heated to 45°C. The medium was then cooled 
to 37°C before addition to macrophage cultures. 
To allow for any possible effects of temperature on 
the culture medium, control medium without agar 
was also heated to 45°C and then cooled before 
use. Cultures were incubated overnight with the 
agar before washing and assaying for Hz02 
production. 
2.6. Cell viability 
Initial cell viability, assessed by eosin exclusion 
was >98%. Adherent cultures were observed by 
phase-contrast microscopy, and in no case did any 
of the treatments described above cause an altera- 
tion in morphology relative to the controls. Fur- 
thermore, none of the treatments caused a decrease 
in total cell protein relative to the control, which 
indicates that cells were remaining adherent. 
2.7. Reproducibility of results 
The results are means of readings from 2 
duplicate wells, in which the variation from the 
mean did not exceed 20%. All experiments were 
performed at least twice, on different days with 
different cell cultures. 
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3. RESULTS AND DISCUSSION Table 2 
3.1. Effect of FeNTA on H202 production 
In the absence of additional iron, production of 
Hz02 was, as expected [l], less for thioglycollate- 
stimulated macrophages than for C. pawurn-, 
activated macrophages (table 1). Addition of 
FeNTA to the cultures for both short (2 h) and 
long (16 h) periods had no effect on either cell 
type. Since it has previously been shown that this 
concentration of FeNTA enhances ferritin produc- 
tion in both types of macrophages, and that iron is 
taken into the cells [2], it must be concluded that 
in neither cell type is iron a limiting factor for 
Hz02 production. 
Effect of DFO (1 mM) on Hz02 production by mouse 
peritoneal macrophages 
Type of 
macrophage 
Elicited 
Activated 
DFO Hz02 release 
(nmol/mg cell protein) 
45 
+ 31 
191 
+ 58 
3.2. Effect of iron depletion on Hz02 production 
Overnight incubation of the macrophage 
cultures with 1 mM DFO prior to triggering for 
Hz02 production showed that in both cell types the 
chelator decreased Hz02 production, particularly 
from C. parvum-activated macrophages (table 2). 
To confirm that DFO was indeed removing in- 
tracellular iron from the macrophages, iron release 
from macrophages previously pulsed with 59Fe- 
transferrin-antitransferrin immune complexes was 
determined in the presence and absence of DFO. It 
was found (table 3) that DFO caused a 7-fold in- 
crease in iron release from thioglycollate- 
stimulated macrophages, and a 3-fold increase 
from C. parvum-activated macrophages. It may 
thus be concluded that while iron is not normally 
a limiting factor for Hz02 production by either 
type of cell, it is nevertheless required as depletion 
of cellular iron by DFO causes reduced Hz02 pro- 
duction. Clearly, though, the reduced Hz02 pro- 
duction by thioglycollate-elicited macrophages 
cannot be explained by a lack of metabolically 
utilisable iron. 
Table 1 
Effect of preincubation with 0.1 mM FeNTA on Hz02 
production by thioglycollate-elicited and C. parvum- 
activated mouse peritoneal macrophages 
3.3. Effect of agar on H202 production 
To determine whether agar ingested in vivo by 
thioglycollate-stimulated macrophages might, as 
suggested by Eichner and Smeaton [3], be respon- 
sible for reduced Hz02 production, both 
thioglycollate-stimulated macrophages and C. 
parvum-activated macrophages were preincubated 
in the presence of 0.5 mg/ml agar (the same con- 
centration as is present in thioglycollate broth). It 
was found (table 4) that agar caused a marked 
reduction of Hz02 production by both cell types. 
However, the effect was much greater on C. 
parvum-activated macrophages which had not 
Type of FeNTA Pre- Hz02 release 
macrophage incubation (nmol/mg 
time (h) cell protein) 
Elicited 2 46 
+ 2 46 
Activated - 2 160 
+ 2 174 
Elicited - 16 114 
+ 16 98 
Activated 16 214 
i- 16 177 
Table 3 
Effect of DFO on iron release by mouse peritoneal 
macrophages pulsed with 59Fe-transferrin-antitrans- 
ferrin immune complexes 
Type of 
macrophage 
Elicited 
Activated 
DFO %e uptake 59Fe release 
(Yo of (To of 
complexes) uptake) 
27 5.1 
+ 33 35.7 
35 10.1 
+ 39 29.8 
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Table 4 
Effect of agar on Hz02 production by mouse peritoneal 
macrophages 
Type of 
macrophage 
Elicited 
Activated 
Agar Hz02 release 
(nmol/mg cell protein) 
26 
+ 7 
182 
+ 12 
previously been exposed to agar (16-fold reduc- 
tion) than on thioglycollate-elicited macrophages 
which had already been exposed to agar in the 
mouse peritoneum (4-fold reduction). It thus 
seems likely that agar ingestion is at least a con- 
tributory factor to the poor production of reactive 
oxygen species by thioglycollate-elicited macro- 
phages . Incubation of C. parvum-activated 
macrophages with agar following a pulse of 59Fe 
transferrin-antitransferrin immune complexes 
showed that agar did not inhibit iron release (not 
shown), indicating that agar did not act at the level 
of sequestering intracellular iron. It was also noted 
that the amount of Hz02 produced by 
thioglycollate-elicited macrophages, while always 
less than that produced by C. parvum-activated 
macrophages, varied considerably from one ex- 
periment to another (tables 1, 2 and 4), and also 
tended to increase if the cells were first incubated 
overnight (cf. table 1). The first observation could 
be explained by a variable degree of in vivo agar in- 
gestion in different mice, depending upon the size 
of the cellular influx, and the second by excretion 
of agar during in vitro culture. 
It may thus be concluded that although iron is 
necessary for Hz02 production by macrophages, it
is not normally a limiting factor. It is also worth 
noting that an alternative hypothesis, namely that 
additional iron might enhance catalysis of the 
Haber-Weiss reaction between Hz02 and superox- 
ide [7] also appears to be untenable as no decrease 
in Hz02 release occurred. The effect of agar on 
Hz02 production suggests that caution may need 
to be exercised in extrapolating from experiments 
with thioglycollate-stimulated macrophages, as the 
broth itself may affect macrophage properties. The 
reason for this effect of agar is not immediately 
obvious, but it could be related to the fact that 
agar can act as a free radical scavenger [3]. A study 
of the effect of agar on the production of other 
reactive oxygen species might help to elucidate the 
mechanism. 
While the effect of agar reported here may be 
considered essentially artifactual, there are wider 
implications with regard to the effect of environ- 
ment on macrophage properties. Ingestion of 
damaged erythrocytes and other cell debris by 
macrophages in inflammatory lesions doubtless 
occurs, and it has been demonstrated that inges- 
tion of erythrocytes reduces the tumoricidal activi- 
ty of activated macrophages [8]. In such situations, 
production of reactive oxygen compounds may 
also be affected, and this could reduce the ability 
of activated macrophages to kill invading 
microorganisms. Preliminary experiments (L.S. 
Stewart and J.H. Brock, unpublished) indicate 
that ingestion of erythrocytes inhibits Hz02 pro- 
duction by activated macrophages, and further 
studies on the effect of environmental factors on 
production of reactive oxygen species by 
macrophages would be of interest. 
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